2019 IHVI Advanced Heart Failure Symposium

2019 IHVI Advanced Heart Failure Symposium is organized by Inova Heart and Vascular Institute (IHVI), Overcome and will be held on Oct 19, 2019 at Marriott Marquis Washington, DC, Washington, Dist of Col, United States of America.

Target Audience:
The program is expected to draw 300 attendees, mostly physicians, from the mid-Atlantic region. Email and print promotional brochures and a journal advertisement will be used to invite attendees. The target audience consists of the following:
• Heart Failure specialists.
• Cardiovascular clinicians.
• Primary care physicians, hospitalists.
• Fellows and residents in training.
• Advanced practice nurses and other non-physician members of the cardiac care team.

Accreditation:
Designation Statement:
The University of Massachusetts Medical School designates this live activity for a maximum of 7 AMA PRA Category 1 Credit(s)™.

Nursing Accreditation (CEUs):
This live activity meets the requirements for up to 8.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04).

Description:
The Inova Heart and Vascular Institute 2019 Advanced Heart Failure Symposium will provide a review of best practices in the field of heart failure, including current guidelines, co-morbidities with a particular emphasis on diabetes, innovative and novel pharmacological and technological treatment options and health policy concerns. The role of mechanical support, the differences in the types of devices, possible complications, and the latest thinking on home monitoring, surgical approaches and transplantation will be presented and discussed in detail, to help physicians to make better informed decisions regarding referral for transplant or mechanical cardiac support.

Through interactive lectures, case studies and panel discussions, world renowned experts will present the very latest research and clinical trial results with an emphasis on the application to day to day clinical practice.

The program will cover the following general topics:
• Guideline Directed Medical Therapy and Novel Approaches to Heart Failure Management.
• Cutting Edge Device Therapy for Heart Failure.
• Treatment Options for Advanced Heart Failure.
• New insights on the Management of Amyloid, HOCM, and other interesting clinical cases.

Educational Objectives:
Upon completion of this course, participants should be able to:
• Understand and apply novel approaches and new pharmacological treatment options for the management of heart failure.
• Utilize novel treatments for mitral regurgitation, comorbidities, and arrhythmias appropriately.
• Delineate the best practices for when to refer advanced heart failure patients for evaluation for heart transplant or mechanical cardiac support.